[go: up one dir, main page]

ES2070087A1 - Indole derivatives - Google Patents

Indole derivatives

Info

Publication number
ES2070087A1
ES2070087A1 ES09301804A ES9301804A ES2070087A1 ES 2070087 A1 ES2070087 A1 ES 2070087A1 ES 09301804 A ES09301804 A ES 09301804A ES 9301804 A ES9301804 A ES 9301804A ES 2070087 A1 ES2070087 A1 ES 2070087A1
Authority
ES
Spain
Prior art keywords
indole derivatives
compounds
useful
vasodilators
migraine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09301804A
Other languages
Spanish (es)
Other versions
ES2070087B1 (en
Inventor
John E Macor
Martin James Wythes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Priority to ES9301804A priority Critical patent/ES2070087B1/en
Publication of ES2070087A1 publication Critical patent/ES2070087A1/en
Application granted granted Critical
Publication of ES2070087B1 publication Critical patent/ES2070087B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compounds of formula I, where W, n, m, R1 and R11 are defined in detail in the report. These compounds are potential serotonin (5-HT1) agonists and are useful for the treatment of migraine and other disorders, also being useful as centrally acting antihypertensives and vasodilators.
ES9301804A 1993-08-13 1993-08-13 DERIVATIVES OF INDOL Expired - Lifetime ES2070087B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9301804A ES2070087B1 (en) 1993-08-13 1993-08-13 DERIVATIVES OF INDOL

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9301804A ES2070087B1 (en) 1993-08-13 1993-08-13 DERIVATIVES OF INDOL

Publications (2)

Publication Number Publication Date
ES2070087A1 true ES2070087A1 (en) 1995-05-16
ES2070087B1 ES2070087B1 (en) 1996-02-16

Family

ID=8282858

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9301804A Expired - Lifetime ES2070087B1 (en) 1993-08-13 1993-08-13 DERIVATIVES OF INDOL

Country Status (1)

Country Link
ES (1) ES2070087B1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0313397A1 (en) * 1987-10-23 1989-04-26 The Wellcome Foundation Limited Therapeutic heterocyclic compounds
EP0438230A2 (en) * 1990-01-17 1991-07-24 MERCK SHARP & DOHME LTD. Indole-substituted five-membered heteroaromatic compounds
WO1991018897A1 (en) * 1990-06-07 1991-12-12 The Wellcome Foundation Limited Therapeutic heterocyclic compounds
WO1992006976A1 (en) * 1990-10-18 1992-04-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivative
WO1992013856A1 (en) * 1991-02-12 1992-08-20 Pfizer Inc. 5-heteroyl indole derivatives
WO1993020073A1 (en) * 1992-04-07 1993-10-14 Pfizer Inc. Indole derivatives as 5-ht1 agonists

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0313397A1 (en) * 1987-10-23 1989-04-26 The Wellcome Foundation Limited Therapeutic heterocyclic compounds
EP0438230A2 (en) * 1990-01-17 1991-07-24 MERCK SHARP & DOHME LTD. Indole-substituted five-membered heteroaromatic compounds
WO1991018897A1 (en) * 1990-06-07 1991-12-12 The Wellcome Foundation Limited Therapeutic heterocyclic compounds
WO1992006976A1 (en) * 1990-10-18 1992-04-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivative
WO1992013856A1 (en) * 1991-02-12 1992-08-20 Pfizer Inc. 5-heteroyl indole derivatives
WO1993020073A1 (en) * 1992-04-07 1993-10-14 Pfizer Inc. Indole derivatives as 5-ht1 agonists

Also Published As

Publication number Publication date
ES2070087B1 (en) 1996-02-16

Similar Documents

Publication Publication Date Title
MY131298A (en) 5-heteroyl indole derivatives
NO983189L (en) New substituted imidazole compounds
AU9102198A (en) Indole-3-carbinol, diindolylmethane and substituted analogs as antiestrogens
HU9503986D0 (en) Perhydroisoindole derivatives as p substance antagonists
HU9501920D0 (en) Indole derivatives as 5-h1-like agonists for use in migraine
PT935465E (en) NEW IMIDAZOLE REPLACED COMPOUNDS
NO931635L (en) PROCEDURE FOR THE PREPARATION OF CHINAZOLINE DERIVATIVES
DZ2043A1 (en) New derivatives.
MY119800A (en) Pyridine derivatives
GR3034854T3 (en) Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors.
PL309225A1 (en) Pharmacologically active derivatives of pyridine and methods of obtaining them
AU3110999A (en) Disubstituted pyrazolines and triazolines as factor xa inhibitors
HUT74992A (en) Use of serotonin antagonist indol derivatives for producing pharmaceutical compositions using for treating fibromyalgia
AU2675095A (en) Indol derivatives useful for the treatment of migraine, composition and utilization
AU2291097A (en) Novel phenanthridines substituted in the 6 position
AU6350699A (en) Chemical compounds
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
YU48698A (en) Carboxamide derivatives of pyrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorder
TR200001102T2 (en) Substituted tetrahydropyrimidinene derivatives, their production and uses.
AU5614198A (en) Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors
AP2001002149A0 (en) Indole derivatives(Priority title)
CA2298820A1 (en) The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
AP2001002045A0 (en) FKBP inhibitors.
YU46302A (en) Substituted pyrroles
ES2070087A1 (en) Indole derivatives